The FDA’s “Breakthrough Therapy Designation” was created
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
On Jul. 9, 2012, the National Institutes of Health (NIH) announced it had awarded a $65 million five…
On Jun. 29, 2012, following a competitive renewal process, the National Cancer Institute announced it had awarded the…
On Jun. 26, 2012, Roche announced it had closed the Nutley plant, established in 1929. The Nutley plant…
On Jun. 25, 2012, the Rocky Mountain Biological Laboratory (RMBL) announced the unveiling of its Legacy Campaign, a…
On Jun. 25, 2012, The St. Louis County Economic Council is opening the doors to its new biotech…
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
On Jun. 13, 2012, in a project led by the Max Planck Institute for Evolutionary Anthropology in Leipzig,…
On Jun. 13, 2012, the Human Microbiome Project announced the completion of a seminal study of microbial diversity….
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
On Jun. 5, 2012, the U.S. Department of Health and Human Services (HHS) Office of the Inspector General…
On Jun. 3, 2012, U.S. Department of Agriculture (USDA) scientists and their colleagues have published the most comprehensive…
On May 31, 2012, the tomato genome was published in Nature, culminating years of work by the Tomato…
On May 25, 2012, Drs. Jennifer Doudna, Emanulle Charpentier, Martin Jinek of UC Berkeley and Krzystof Chylinski of…
May 22, 2012, AZBio led a cross industry coalition to amend Arizona’s Open Records Law to make the…
On May 1, 2012, Pfizer and Protalix BioTherapeutics announced that the U.S. Food and Drug Administration (FDA) had approved…
On Apr. 30, 2012, Hologic announced the acquisition of San Diego-based Gen-Probe, a molecular diagnostics company, for $3.7…
On Apr. 30, 2012, “Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database…
On Apr. 25, 2012, U.S. Representatives Jim Cooper (D-Tenn.), Charlie Dent (R-Pa.), and Robert J. Dold (R-Ill.) joined…
On Apr. 24, 2012, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. U.S. Since mid-2011, a…
On Mar. 29, 2012, the U.S. Centers for Disease Control and Prevention (CDC) reported that death rates from…
On Mar. 27, 2012, the American Chemical Society awarded it’s 2012 Priestley Medal to Robert S. Langer “to recognize…
On Mar. 26, 2012, researchers at Stanford University School of Medicine reported study results that showed human tumors…
On Mar. 8, 2012, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a five-year, $21 million…
On Mar. 7, 2012, an international team led by researchers at the Wellcome Trust Sanger Institute announced they…
On Feb. 27, 2012, the Duke Cancer Institute opened a new 267,000-square-foot, $235 million Cancer Center that included…
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
On Feb. 17, 2012, the FDA announced Korlym (mifepristone) was approved to control high blood sugar levels (hyperglycemia)…
On Feb. 7, 2012, The Max Planck Institute for Evolutionary Anthropology, in Leipzig, Germany, completed the genome sequence…